The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
The global Atropine market was valued at US$ 510 million in 2020 and is expected to reach US$ 452 million by the end of 2027, growing at a CAGR of -1.7% during 2021-2027.
This report focuses on Atropine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Atropine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Atropine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Injection
Drop
Gel
Segment by Application
Gastrointestinal
Ophthalmology
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
The global Atropine market was valued at US$ 510 million in 2020 and is expected to reach US$ 452 million by the end of 2027, growing at a CAGR of -1.7% during 2021-2027.
This report focuses on Atropine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Atropine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Atropine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Injection
Drop
Gel
Segment by Application
Gastrointestinal
Ophthalmology
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Index1 Atropine Market Overview
1.1 Product Overview and Scope of Atropine
1.2 Atropine Segment by Type
1.2.1 Global Atropine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Injection
1.2.3 Drop
1.2.4 Gel
1.3 Atropine Segment by Application
1.3.1 Global Atropine Sales Comparison by Application: (2021-2027)
1.3.2 Gastrointestinal
1.3.3 Ophthalmology
1.3.4 Other
1.4 Global Atropine Market Size Estimates and Forecasts
1.4.1 Global Atropine Revenue 2016-2027
1.4.2 Global Atropine Sales 2016-2027
1.4.3 Atropine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Atropine Market Competition by Manufacturers
2.1 Global Atropine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Atropine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Atropine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Atropine Manufacturing Sites, Area Served, Product Type
2.5 Atropine Market Competitive Situation and Trends
2.5.1 Atropine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Atropine Players Market Share by Revenue
2.5.3 Global Atropine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atropine Retrospective Market Scenario by Region
3.1 Global Atropine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Atropine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Atropine Market Facts & Figures by Country
3.3.1 North America Atropine Sales by Country
3.3.2 North America Atropine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Atropine Market Facts & Figures by Country
3.4.1 Europe Atropine Sales by Country
3.4.2 Europe Atropine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Atropine Market Facts & Figures by Region
3.5.1 Asia Pacific Atropine Sales by Region
3.5.2 Asia Pacific Atropine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Atropine Market Facts & Figures by Country
3.6.1 Latin America Atropine Sales by Country
3.6.2 Latin America Atropine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Atropine Market Facts & Figures by Country
3.7.1 Middle East and Africa Atropine Sales by Country
3.7.2 Middle East and Africa Atropine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Atropine Historic Market Analysis by Type
4.1 Global Atropine Sales Market Share by Type (2016-2021)
4.2 Global Atropine Revenue Market Share by Type (2016-2021)
4.3 Global Atropine Price by Type (2016-2021)
5 Global Atropine Historic Market Analysis by Application
5.1 Global Atropine Sales Market Share by Application (2016-2021)
5.2 Global Atropine Revenue Market Share by Application (2016-2021)
5.3 Global Atropine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 C²PHARMA
6.1.1 C²PHARMA Corporation Information
6.1.2 C²PHARMA Description and Business Overview
6.1.3 C²PHARMA Atropine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 C²PHARMA Atropine Product Portfolio
6.1.5 C²PHARMA Recent Developments/Updates
6.2 RESONANCE LABORATORIES
6.2.1 RESONANCE LABORATORIES Corporation Information
6.2.2 RESONANCE LABORATORIES Description and Business Overview
6.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 RESONANCE LABORATORIES Atropine Product Portfolio
6.2.5 RESONANCE LABORATORIES Recent Developments/Updates
6.3 ROLABO OUTSOURCING
6.3.1 ROLABO OUTSOURCING Corporation Information
6.3.2 ROLABO OUTSOURCING Description and Business Overview
6.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 ROLABO OUTSOURCING Atropine Product Portfolio
6.3.5 ROLABO OUTSOURCING Recent Developments/Updates
6.4 Minsheng
6.4.1 Minsheng Corporation Information
6.4.2 Minsheng Description and Business Overview
6.4.3 Minsheng Atropine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Minsheng Atropine Product Portfolio
6.4.5 Minsheng Recent Developments/Updates
6.5 CR Double-Crane
6.5.1 CR Double-Crane Corporation Information
6.5.2 CR Double-Crane Description and Business Overview
6.5.3 CR Double-Crane Atropine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 CR Double-Crane Atropine Product Portfolio
6.5.5 CR Double-Crane Recent Developments/Updates
6.6 HENAN PURUI
6.6.1 HENAN PURUI Corporation Information
6.6.2 HENAN PURUI Description and Business Overview
6.6.3 HENAN PURUI Atropine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 HENAN PURUI Atropine Product Portfolio
6.6.5 HENAN PURUI Recent Developments/Updates
6.7 Albany Molecular Research
6.6.1 Albany Molecular Research Corporation Information
6.6.2 Albany Molecular Research Description and Business Overview
6.6.3 Albany Molecular Research Atropine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Albany Molecular Research Atropine Product Portfolio
6.7.5 Albany Molecular Research Recent Developments/Updates
6.8 Alchem International
6.8.1 Alchem International Corporation Information
6.8.2 Alchem International Description and Business Overview
6.8.3 Alchem International Atropine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Alchem International Atropine Product Portfolio
6.8.5 Alchem International Recent Developments/Updates
6.9 SAURAV CHEMICALS
6.9.1 SAURAV CHEMICALS Corporation Information
6.9.2 SAURAV CHEMICALS Description and Business Overview
6.9.3 SAURAV CHEMICALS Atropine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 SAURAV CHEMICALS Atropine Product Portfolio
6.9.5 SAURAV CHEMICALS Recent Developments/Updates
6.10 Katsura Chemical
6.10.1 Katsura Chemical Corporation Information
6.10.2 Katsura Chemical Description and Business Overview
6.10.3 Katsura Chemical Atropine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Katsura Chemical Atropine Product Portfolio
6.10.5 Katsura Chemical Recent Developments/Updates
6.11 Hangzhou Vega
6.11.1 Hangzhou Vega Corporation Information
6.11.2 Hangzhou Vega Atropine Description and Business Overview
6.11.3 Hangzhou Vega Atropine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Hangzhou Vega Atropine Product Portfolio
6.11.5 Hangzhou Vega Recent Developments/Updates
6.12 Wuhan senwayer century
6.12.1 Wuhan senwayer century Corporation Information
6.12.2 Wuhan senwayer century Atropine Description and Business Overview
6.12.3 Wuhan senwayer century Atropine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Wuhan senwayer century Atropine Product Portfolio
6.12.5 Wuhan senwayer century Recent Developments/Updates
7 Atropine Manufacturing Cost Analysis
7.1 Atropine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Atropine
7.4 Atropine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Atropine Distributors List
8.3 Atropine Customers
9 Atropine Market Dynamics
9.1 Atropine Industry Trends
9.2 Atropine Growth Drivers
9.3 Atropine Market Challenges
9.4 Atropine Market Restraints
10 Global Market Forecast
10.1 Atropine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Atropine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Atropine by Type (2022-2027)
10.2 Atropine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Atropine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Atropine by Application (2022-2027)
10.3 Atropine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Atropine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Atropine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Atropine Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Atropine Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Atropine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Atropine Covered in This Study
Table 5. Global Atropine Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Atropine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Atropine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Atropine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Atropine Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Atropine Manufacturing Sites and Area Served
Table 11. Manufacturers Atropine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Atropine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atropine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Atropine Sales by Region (2016-2021) & (Kg)
Table 16. Global Atropine Sales Market Share by Region (2016-2021)
Table 17. Global Atropine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Atropine Sales by Country (2016-2021) & (Kg)
Table 19. North America Atropine Sales Market Share by Country (2016-2021)
Table 20. North America Atropine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Atropine Revenue Market Share by Country (2016-2021)
Table 22. Europe Atropine Sales by Country (2016-2021) & (Kg)
Table 23. Europe Atropine Sales Market Share by Country (2016-2021)
Table 24. Europe Atropine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Atropine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Atropine Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Atropine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Atropine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Atropine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Atropine Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Atropine Sales Market Share by Country (2016-2021)
Table 32. Latin America Atropine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Atropine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Atropine Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Atropine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Atropine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Atropine Revenue Market Share by Country (2016-2021)
Table 38. Global Atropine Sales (Kg) by Type (2016-2021)
Table 39. Global Atropine Sales Market Share by Type (2016-2021)
Table 40. Global Atropine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Atropine Revenue Share by Type (2016-2021)
Table 42. Global Atropine Price (USD/Kg) by Type (2016-2021)
Table 43. Global Atropine Sales (Kg) by Application (2016-2021)
Table 44. Global Atropine Sales Market Share by Application (2016-2021)
Table 45. Global Atropine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Atropine Revenue Share by Application (2016-2021)
Table 47. Global Atropine Price (USD/Kg) by Application (2016-2021)
Table 48. C²PHARMA Corporation Information
Table 49. C²PHARMA Description and Business Overview
Table 50. C²PHARMA Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. C²PHARMA Atropine Product
Table 52. C²PHARMA Recent Developments/Updates
Table 53. RESONANCE LABORATORIES Corporation Information
Table 54. RESONANCE LABORATORIES Description and Business Overview
Table 55. RESONANCE LABORATORIES Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. RESONANCE LABORATORIES Atropine Product
Table 57. RESONANCE LABORATORIES Recent Developments/Updates
Table 58. ROLABO OUTSOURCING Corporation Information
Table 59. ROLABO OUTSOURCING Description and Business Overview
Table 60. ROLABO OUTSOURCING Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. ROLABO OUTSOURCING Atropine Product
Table 62. ROLABO OUTSOURCING Recent Developments/Updates
Table 63. Minsheng Corporation Information
Table 64. Minsheng Description and Business Overview
Table 65. Minsheng Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Minsheng Atropine Product
Table 67. Minsheng Recent Developments/Updates
Table 68. CR Double-Crane Corporation Information
Table 69. CR Double-Crane Description and Business Overview
Table 70. CR Double-Crane Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. CR Double-Crane Atropine Product
Table 72. CR Double-Crane Recent Developments/Updates
Table 73. HENAN PURUI Corporation Information
Table 74. HENAN PURUI Description and Business Overview
Table 75. HENAN PURUI Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. HENAN PURUI Atropine Product
Table 77. HENAN PURUI Recent Developments/Updates
Table 78. Albany Molecular Research Corporation Information
Table 79. Albany Molecular Research Description and Business Overview
Table 80. Albany Molecular Research Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Albany Molecular Research Atropine Product
Table 82. Albany Molecular Research Recent Developments/Updates
Table 83. Alchem International Corporation Information
Table 84. Alchem International Description and Business Overview
Table 85. Alchem International Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Alchem International Atropine Product
Table 87. Alchem International Recent Developments/Updates
Table 88. SAURAV CHEMICALS Corporation Information
Table 89. SAURAV CHEMICALS Description and Business Overview
Table 90. SAURAV CHEMICALS Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. SAURAV CHEMICALS Atropine Product
Table 92. SAURAV CHEMICALS Recent Developments/Updates
Table 93. Katsura Chemical Corporation Information
Table 94. Katsura Chemical Description and Business Overview
Table 95. Katsura Chemical Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. Katsura Chemical Atropine Product
Table 97. Katsura Chemical Recent Developments/Updates
Table 98. Hangzhou Vega Corporation Information
Table 99. Hangzhou Vega Description and Business Overview
Table 100. Hangzhou Vega Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. Hangzhou Vega Atropine Product
Table 102. Hangzhou Vega Recent Developments/Updates
Table 103. Wuhan senwayer century Corporation Information
Table 104. Wuhan senwayer century Description and Business Overview
Table 105. Wuhan senwayer century Atropine Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Wuhan senwayer century Atropine Product
Table 107. Wuhan senwayer century Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Atropine Distributors List
Table 111. Atropine Customers List
Table 112. Atropine Market Trends
Table 113. Atropine Growth Drivers
Table 114. Atropine Market Challenges
Table 115. Atropine Market Restraints
Table 116. Global Atropine Sales Forecast by Type (2022-2027) & (Kg)
Table 117. Global Atropine Sales Market Share Forecast by Type (2022-2027)
Table 118. Global Atropine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 119. Global Atropine Revenue Market Share Forecast by Type (2022-2027)
Table 120. Global Atropine Sales Forecast by Application (2022-2027) & (Kg)
Table 121. Global Atropine Sales Market Share Forecast by Application (2022-2027)
Table 122. Global Atropine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 123. Global Atropine Revenue Market Share Forecast by Application (2022-2027)
Table 124. Global Atropine Sales Forecast by Region (2022-2027) & (Kg)
Table 125. Global Atropine Sales Market Share Forecast by Region (2022-2027)
Table 126. Global Atropine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 127. Global Atropine Revenue Market Share Forecast by Region (2022-2027)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Atropine
Figure 2. Global Atropine Market Share by Type in 2020 & 2027
Figure 3. Injection Product Picture
Figure 4. Drop Product Picture
Figure 5. Gel Product Picture
Figure 6. Global Atropine Market Share by Application in 2020 & 2027
Figure 7. Gastrointestinal
Figure 8. Ophthalmology
Figure 9. Other
Figure 10. Global Atropine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Atropine Market Size 2016-2027 (US$ Million)
Figure 12. Global Atropine Sales 2016-2027 (Kg)
Figure 13. Global Atropine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Atropine Sales Share by Manufacturers in 2020
Figure 15. Global Atropine Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Atropine Players: Market Share by Revenue in 2020
Figure 17. Atropine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Atropine Sales Market Share by Region (2016-2021)
Figure 19. Global Atropine Sales Market Share by Region in 2020
Figure 20. Global Atropine Revenue Market Share by Region (2016-2021)
Figure 21. Global Atropine Revenue Market Share by Region in 2020
Figure 22. U.S. Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Atropine by Type (2016-2021)
Figure 47. Sales Market Share of Atropine by Application (2016-2021)
Figure 48. Sales Market Share of Atropine by Application in 2020
Figure 49. Revenue Share of Atropine by Application (2016-2021)
Figure 50. Revenue Share of Atropine by Application in 2020
Figure 51. Manufacturing Cost Structure of Atropine
Figure 52. Manufacturing Process Analysis of Atropine
Figure 53. Atropine Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
